We publish routine updates to performance data for the assessment of clinical trials and established medicines within 15 days of the end of each month. This is to help improve the predictability of decision making in applications for clinical trials, marketing authorisations and variations to existing approvals.
Updates to this page
Published 14 April 2023 Last updated 20 November 2024 +show all updates
Webinar link for 17 October 2024 added to MHRA performance data for assessment of clinical trials and established medicines page.
Added new performance metricsPerformance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (Clinical Trials - September 2023 November 2024) (Clinical Investigations September 2023 November2024) - file attachment createdPerformance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - November 2024) - file attachment createdMHRA performance data for assessment of clinical trials and established medicines - HTML attachment updated
Updated Performance metrics for October 2024
Added Performance data for September 2024
Published: Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - July 2024)Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (Clinical Trials - September 2023 June 2024) (Clinical Investigations July 2023 July 2024)
Published:Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (Clinical Trials - September 2023 June 2024) (Clinical Investigations July 2023 June 2024)Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - June 2024)
Added Performance Metrics: Assessment of Clinical Trial Authorisation Applications and performance Metrics: Assessment of New Marketing Authorisation Applications and Variations and updated HTML to reflect updates.
Published - Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (Clinical Trials: September 2023 - April 2024) (Clinical Investigations: May 2023 - April 2024) and- Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - April 2024)
Published 'Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (Clinical Trials: September 2023 - March 2024) (Clinical Investigations: April 2023 - March 2024) &Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - March 2024)
Published Clinical Trials Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (February 2023 February 2024) & Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 February 2024).
Published 'Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 January 2024)' & 'Clinical Trials Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (February 2023 January 2024)'
Published 'Performance Metrics January 2023 December 2023: Assessment of New Marketing Authorisation Applications and Variations' and 'Clinical Trials Performance Metrics: December 2022 - December 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments'
Published 'Clinical Trials Performance Metrics: December 2022 - November 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments' and 'Performance Metrics January 2023 November 2023: Assessment of New Marketing Authorisation Applications and Variations'.
Published 'Clinical Trials Performance Metrics: November 2022 - October 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments' & 'Performance Metrics January 2023 October 2023: Assessment of New Marketing Authorisation Applications and Variations'
Published 'Clinical Trials Performance Metrics: October 2022 -September 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments' and 'Performance Metrics January 2023 September 2023: Assessment of New Marketing Authorisation Applications and Variations'.
Published 'Clinical Trials Performance Metrics: September 2022 - August
